Evidence map›Paper›PMID 32900761›Full record

ArticleBMJ open2020

Cancer Loyalty Card Study (CLOCS): protocol for an observational case-control study focusing on the patient interval in ovarian cancer diagnosis.

Hannah R Brewer, Yasemin Hirst, Sudha Sundar, Marc Chadeau-Hyam, James M Flanagan

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03994653 (Cancer Loyalty Card Study), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03994653 completednot on this map

Cancer Loyalty Card Study: a Retrospective Observational Case-Control Study

TypeobservationalSponsorImperial College LondonRan2019 to 2022Enrolled963ConditionsOvarian NeoplasmsArmsRisk Factor Questionnaire, Clinical Questionnaire
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Review
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Hannah R BrewerSurgery and Cancer, Imperial College London, London, UK.
Yasemin HirstBehavioural Science and Health, University College London, London, UK.
Sudha SundarInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Marc Chadeau-HyamMRC Centre for Environment and Health, Imperial College London, London, UK.
James M FlanaganSurgery and Cancer, Imperial College London, London, UK j.flanagan@imperial.ac.uk.ORCID 0000-0003-4955-1383
Imperial College London · GBBirmingham City Hospital · GBMRC Centre for Environment and HealthUniversity College London · GB

Funding

Cancer Research UK 26726Cancer Research UK C38463/A26726Medical Research Council MR/S019669/1
6 · The paper itself

Abstract

introductionOvarian cancer is the eighth most common cancer in women worldwide, and about 1 in 5 women with ovarian cancer do not receive treatment, because they are too unwell by the time they are diagnosed. Symptoms of ovarian cancer are non-specific or can be associated with other common conditions, and women experiencing these symptoms have been shown to self-manage them using over-the-counter medication. Results from a recent proof-of-concept study suggest there may be an increase in the purchases of painkillers and indigestion medication 10-12 months before ovarian cancer diagnosis. We propose a case-control study, as part of a larger project called the Cancer Loyalty Card Study (CLOCS), to investigate whether a significant change in medication purchases could be an indication for early signs of ovarian cancer, using data already collected through store loyalty cards. METHODS AND ANALYSIS: Using a retrospective case-control design, we aim to recruit 500 women diagnosed with ovarian cancer (cases) and 500 women without ovarian cancer (controls) in the UK who hold a loyalty card with at least one participating high street retailer. We will use pre-existing loyalty card data to compare past purchase patterns of cases with those of controls. In order to assess ovarian cancer risk in participants and their purchase patterns, we will collect information from participants on ovarian cancer risk factors and clinical data including symptoms experienced before diagnosis from recruited women with ovarian cancer. ETHICS AND DISSEMINATION: CLOCS was reviewed and approved by the North West-Greater Manchester South Research Ethics Committee (19/NW/0427). Study outcomes will be disseminated through academic publications, the study website, social media and a report to the research sites that support the study once results are published. TRIAL REGISTRATION NUMBER: ISRCTN 14897082, CPMS 43323, NCT03994653.

Indexed as

Ovarian NeoplasmsCarcinoma, Ovarian EpithelialCase-Control StudiesFemaleHumansObservational Studies as TopicRetrospective StudiesRisk Factorsepidemiologygynaecological oncologyoncologypublic health

Identifiers

PMID32900761
PMCPMC7484869
OpenAlexW3083914267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.